| __timestamp | Alpine Immune Sciences, Inc. | Ascendis Pharma A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 19698000 |
| Thursday, January 1, 2015 | 16054000 | 40528000 |
| Friday, January 1, 2016 | 23316000 | 66022000 |
| Sunday, January 1, 2017 | 10626000 | 99589000 |
| Monday, January 1, 2018 | 28970000 | 140281000 |
| Tuesday, January 1, 2019 | 35847000 | 191621000 |
| Wednesday, January 1, 2020 | 27185000 | 260904000 |
| Friday, January 1, 2021 | 58742000 | 295867000 |
| Saturday, January 1, 2022 | 70243000 | 379624000 |
| Sunday, January 1, 2023 | 80904000 | 413454000 |
| Monday, January 1, 2024 | 307004000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Ascendis Pharma A/S and Alpine Immune Sciences, Inc. have demonstrated contrasting trajectories in their R&D investments. Ascendis Pharma A/S has consistently outpaced Alpine Immune Sciences, with its R&D expenses growing by over 2,000% from 2014 to 2023. By 2023, Ascendis Pharma's R&D spending reached a staggering 413 million, reflecting its aggressive pursuit of groundbreaking therapies.
Conversely, Alpine Immune Sciences has shown a more modest increase, with its R&D expenses rising by approximately 560% over the same period. This growth, while significant, highlights a more cautious approach to innovation. The data underscores the varying strategies within the biotech sector, where companies balance risk and reward in their quest to develop life-changing treatments.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc.